Welcome to LookChem.com Sign In|Join Free
  • or
HNE, also known as 4-hydroxynonenal, is a lipid peroxidation product derived from oxidized ω-6 polyunsaturated fatty acids such as arachidonic acid. It exhibits various biological activities, including cytotoxicity, growth-inhibiting activity, genotoxicity, and chemotactic activity. HNE plays a significant role in cellular processes and has potential applications in various fields due to its unique properties.

75899-68-2

Post Buying Request

75899-68-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

75899-68-2 Usage

Uses

Used in Biochemical Research:
HNE is used as a marker of lipid peroxidation for [application reason] studying the effects of oxidative stress on cellular processes and understanding the mechanisms behind various diseases related to oxidative stress.
Used in Pharmaceutical Industry:
HNE is used as an irreversible inhibitor of Na+/K+-ATPase activity for [application reason] developing drugs that target this enzyme, which plays a crucial role in maintaining cellular ion balance and overall cellular function.

Check Digit Verification of cas no

The CAS Registry Mumber 75899-68-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,8,9 and 9 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 75899-68:
(7*7)+(6*5)+(5*8)+(4*9)+(3*9)+(2*6)+(1*8)=202
202 % 10 = 2
So 75899-68-2 is a valid CAS Registry Number.

75899-68-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name HNE

1.2 Other means of identification

Product number -
Other names 4-hydroxy-trans-2-nonenal

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:75899-68-2 SDS

75899-68-2Synthetic route

4-hydroxy-2-trans-nonenal dimethylacetal
109296-10-8

4-hydroxy-2-trans-nonenal dimethylacetal

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With sulfuric acid In tetrahydrofuran; water for 1h; Ambient temperature;97%
With sulfuric acid Yield given;
With hydrogen cation In water Hydrolysis;
With hydrogenchloride In water
With hydrogenchloride In water at 20℃; for 1h; pH=3; Darkness; Inert atmosphere;
C27H29O6(1-)*K(1+)

C27H29O6(1-)*K(1+)

A

1-hydroxy-2-propyl-9,10-anthraquinone-4-carboxylic acid
1086461-21-3

1-hydroxy-2-propyl-9,10-anthraquinone-4-carboxylic acid

B

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Stage #1: C27H29O6(1-)*K(1+) In water for 2.5h; pH=9; aq. buffer; Irradiation;
Stage #2: With hydrogenchloride In water
A n/a
B 97%
(±)-anti-4-(2-hydroxyethyl)-5-pentyl-1,3-dioxolan-2-one

(±)-anti-4-(2-hydroxyethyl)-5-pentyl-1,3-dioxolan-2-one

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione In ethyl acetate for 3h; Reagent/catalyst; Solvent; Inert atmosphere; Reflux; stereoselective reaction;94%
With 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione In ethyl acetate for 3h; Inert atmosphere; Reflux; stereoselective reaction;80%
2-{1-[(E)-2-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-vinyl]-hexyloxy}-tetrahydro-pyran
206050-60-4

2-{1-[(E)-2-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-vinyl]-hexyloxy}-tetrahydro-pyran

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With sodium periodate; acetic acid In water93%
(E)-4-(tert-butyldimethylsilyloxy)-2-nonenal
130796-43-9

(E)-4-(tert-butyldimethylsilyloxy)-2-nonenal

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With hydrogen fluoride In acetonitrile for 1h;88%
(methoxymethylene)triphenylphosphorane
20763-19-3

(methoxymethylene)triphenylphosphorane

2,3-epoxyoctanal
42134-50-9

2,3-epoxyoctanal

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
In tetrahydrofuran at -78 - 20℃;83%
3-(tert-butyldimethylsilyl)-2,3-epoxypropyl p-tolyl sulfone

3-(tert-butyldimethylsilyl)-2,3-epoxypropyl p-tolyl sulfone

hexanal
66-25-1

hexanal

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Stage #1: 3-(tert-butyldimethylsilyl)-2,3-epoxypropyl p-tolyl sulfone; hexanal With sodium hexamethyldisilazane In tetrahydrofuran at -80 - -60℃; for 0.333333h;
Stage #2: With ethanol; tetrabutyl ammonium fluoride; acetic acid In tetrahydrofuran at -80℃; for 0.166667h;
77%
1-octen-3-ol
3391-86-4

1-octen-3-ol

acrolein
107-02-8

acrolein

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With Hoveyda-Grubbs catalyst 2nd generation In dichloromethane at 20℃; for 20h;75%
(E)-4-[(tetrahydro-2H-pyran-2-yl)oxy]-2-nonenal
1256782-46-3

(E)-4-[(tetrahydro-2H-pyran-2-yl)oxy]-2-nonenal

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With toluene-4-sulfonic acid In methanol at 0 - 20℃; for 2h;70%
With toluene-4-sulfonic acid In methanol
With toluene-4-sulfonic acid
1,1,4-tris(acetyloxy)-2-(E)-nonene

1,1,4-tris(acetyloxy)-2-(E)-nonene

A

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

B

4-acetyloxy-2-(E)-nonenal
37423-49-7

4-acetyloxy-2-(E)-nonenal

Conditions
ConditionsYield
With lipase In phosphate buffer at 37℃; for 0.25h; Product distribution; Further Variations:; reaction time;A 43%
B 57%
1-Bromopentane
110-53-2

1-Bromopentane

(2E)-4,4-dimethoxybut-2-enal
18778-96-6, 4093-49-6

(2E)-4,4-dimethoxybut-2-enal

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Stage #1: 1-Bromopentane With magnesium In diethyl ether
Stage #2: (2E)-4,4-dimethoxybut-2-enal In diethyl ether at 0 - 20℃; for 1.5h;
44%
methanol
67-56-1

methanol

1-(4-hydroxy-2-nonenyloxy)-2-propyl-9,10-anthraquinone
791615-15-1

1-(4-hydroxy-2-nonenyloxy)-2-propyl-9,10-anthraquinone

A

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

B

1-Hydroxy-2-propyl-9,10-anthraquinone
156334-29-1

1-Hydroxy-2-propyl-9,10-anthraquinone

C

2-(3-hydroxy-oct-1-enyl)-11b-methoxy-4-propyl-11bH-1,3-dioxa-benzo[de]anthracen-7-one
791808-24-7

2-(3-hydroxy-oct-1-enyl)-11b-methoxy-4-propyl-11bH-1,3-dioxa-benzo[de]anthracen-7-one

Conditions
ConditionsYield
for 5h; Irradiation;A 30%
B 32%
C 42%
1,1-dimethoxy-non-2t-ene
18287-01-9

1,1-dimethoxy-non-2t-ene

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
(i) NBS, AIBN, CCl4, (ii) Ag2O, H2O, acetone, (iii) aq. citric acid; Multistep reaction;
linoleic acid
60-33-3

linoleic acid

A

pentanal
110-62-3

pentanal

B

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

C

butyraldehyde
123-72-8

butyraldehyde

D

hexanal
66-25-1

hexanal

Conditions
ConditionsYield
With air at 37℃; for 24h; Product distribution; other unsaturated fatty acids;
(E,E)-2,4-nonadienal
5910-87-2

(E,E)-2,4-nonadienal

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With triethylsilane; [5,10,15,20-tetra(2,6-dichlorophenyl)porphyrinato]cobalt(II); oxygen; phosphorous acid trimethyl ester 1.) 2-propanol, CH2Cl2, 28 deg C, 1.5 h, 1 atm, 2.) 2-propanol, CH2Cl2, 2 h, r.t.; Yield given. Multistep reaction;
13-[S-(Z,E)]-9,11-Hydroperoxyoctadecadienoic acid

13-[S-(Z,E)]-9,11-Hydroperoxyoctadecadienoic acid

A

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

B

(2E)-4-oxo-2-nonenal
103560-62-9

(2E)-4-oxo-2-nonenal

C

(E)-4-Hydroperoxy-2-nonenal
7439-43-2

(E)-4-Hydroperoxy-2-nonenal

Conditions
ConditionsYield
With ammonium sulfate; potassium phosphate buffer; iron(II) sulfate at 37℃; for 0.5h; pH=7.0; Product distribution; Further Variations:; Reagents; reaction time;
3,4-epoxynonanol
208119-82-8

3,4-epoxynonanol

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With pyridinium chlorochromate In dichloromethane at 20℃;8.6 mg
(E)-1,1-dimethoxy-2-nonen-4-one
194291-91-3

(E)-1,1-dimethoxy-2-nonen-4-one

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With sodium tetrahydroborate
4-hydroxy-trans-non-2-enal diethylacetal
18445-69-7

4-hydroxy-trans-non-2-enal diethylacetal

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
With hydrogenchloride at 20℃; for 1h;
methanol
67-56-1

methanol

1-(4-hydroxy-2-nonenyloxy)-2-propyl-9,10-anthraquinone
791615-15-1

1-(4-hydroxy-2-nonenyloxy)-2-propyl-9,10-anthraquinone

A

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

B

4-hydroxy-2-trans-nonenal dimethylacetal
109296-10-8

4-hydroxy-2-trans-nonenal dimethylacetal

C

1-Hydroxy-2-propyl-9,10-anthraquinone
156334-29-1

1-Hydroxy-2-propyl-9,10-anthraquinone

Conditions
ConditionsYield
With oxygen In water for 3h; Product distribution; Further Variations:; Reagents; Solvents; Irradiation;
2-(3-hydroxy-oct-1-enyl)-11b-methoxy-4-propyl-11bH-1,3-dioxa-benzo[de]anthracen-7-one
791808-24-7

2-(3-hydroxy-oct-1-enyl)-11b-methoxy-4-propyl-11bH-1,3-dioxa-benzo[de]anthracen-7-one

A

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

B

1-Hydroxy-2-propyl-9,10-anthraquinone
156334-29-1

1-Hydroxy-2-propyl-9,10-anthraquinone

Conditions
ConditionsYield
In methanol Irradiation;
n-pentylmagnesium bromide
693-25-4

n-pentylmagnesium bromide

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 83 percent / tetrahydrofuran / 0.25 h / 0 °C
2: 64 percent / TBAF / tetrahydrofuran; dimethylformamide / 5 h / 20 °C
3: 42 percent / 5 h / Irradiation
4: methanol / Irradiation
View Scheme
Multi-step reaction with 2 steps
1: 84 percent / tetrahydrofuran / 1.5 h / -40 - -15 °C
2: 97 percent / 2.5percent aq. H2SO4 / tetrahydrofuran; H2O / 1 h / Ambient temperature
View Scheme
1-bromo-4-hydroxy-(E)-2-nonene
98262-71-6

1-bromo-4-hydroxy-(E)-2-nonene

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 64 percent / TBAF / tetrahydrofuran; dimethylformamide / 5 h / 20 °C
2: 42 percent / 5 h / Irradiation
3: methanol / Irradiation
View Scheme
1-(4-hydroxy-2-nonenyloxy)-2-propyl-9,10-anthraquinone
791615-15-1

1-(4-hydroxy-2-nonenyloxy)-2-propyl-9,10-anthraquinone

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 42 percent / 5 h / Irradiation
2: methanol / Irradiation
View Scheme
n-pentylmagnesium bromide
693-25-4

n-pentylmagnesium bromide

tricyclohexyl germanium-bromide

tricyclohexyl germanium-bromide

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. NH4Cl
2: H+ / H2O
View Scheme
TETRAHYDROPYRANE
142-68-7

TETRAHYDROPYRANE

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: NaI, CaCO3 / tetrahydrofuran
2: 1.) Mg / 1.) Et2O, 1 h, 2.) Et2O, 30 min
3: 97 percent / PPTS / CH2Cl2 / Ambient temperature
4: 99 percent / n-Bu4NF / tetrahydrofuran / Ambient temperature
5: 91 percent / DMAP / CH2Cl2 / 18 h / 0 - 5 °C
6: 80 percent / NaBH4 / dimethylsulfoxide / 2 h / 85 °C
7: 93 percent / NaIO4, AcOH / H2O
View Scheme
tert-butyl((5-iodopentyl)oxy)dimethylsilane
85514-45-0

tert-butyl((5-iodopentyl)oxy)dimethylsilane

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 1.) Mg / 1.) Et2O, 1 h, 2.) Et2O, 30 min
2: 97 percent / PPTS / CH2Cl2 / Ambient temperature
3: 99 percent / n-Bu4NF / tetrahydrofuran / Ambient temperature
4: 91 percent / DMAP / CH2Cl2 / 18 h / 0 - 5 °C
5: 80 percent / NaBH4 / dimethylsulfoxide / 2 h / 85 °C
6: 93 percent / NaIO4, AcOH / H2O
View Scheme
(1E)-(3,3-dimethyl-2,4-dioxolanyl)oct-1-en-3-ol

(1E)-(3,3-dimethyl-2,4-dioxolanyl)oct-1-en-3-ol

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 97 percent / PPTS / CH2Cl2 / Ambient temperature
2: 93 percent / NaIO4, AcOH / H2O
View Scheme
(E)-8-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-6-(tetrahydro-pyran-2-yloxy)-oct-7-en-1-ol
206050-56-8

(E)-8-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-6-(tetrahydro-pyran-2-yloxy)-oct-7-en-1-ol

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 91 percent / DMAP / CH2Cl2 / 18 h / 0 - 5 °C
2: 80 percent / NaBH4 / dimethylsulfoxide / 2 h / 85 °C
3: 93 percent / NaIO4, AcOH / H2O
View Scheme
(1E)-1-[3,3-dimethyl-(2,4-dioxolanyl)-8-(1,1,2,2-tetramethyl)-1-silapropoxy]oct-1-en-3-ol
206050-53-5

(1E)-1-[3,3-dimethyl-(2,4-dioxolanyl)-8-(1,1,2,2-tetramethyl)-1-silapropoxy]oct-1-en-3-ol

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 97 percent / PPTS / CH2Cl2 / Ambient temperature
2: 99 percent / n-Bu4NF / tetrahydrofuran / Ambient temperature
3: 91 percent / DMAP / CH2Cl2 / 18 h / 0 - 5 °C
4: 80 percent / NaBH4 / dimethylsulfoxide / 2 h / 85 °C
5: 93 percent / NaIO4, AcOH / H2O
View Scheme
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

N-acetylhistamine
673-49-4

N-acetylhistamine

Nα-acetyl-Nτ-(2-hydroxy-5-pentyltetrahydrofuran-4-yl)histamine

Nα-acetyl-Nτ-(2-hydroxy-5-pentyltetrahydrofuran-4-yl)histamine

Conditions
ConditionsYield
With phosphate buffer In acetonitrile at 37℃; for 24h; Addition; cyclization;86%
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

pentafluorophenyl hydrazine
828-73-9

pentafluorophenyl hydrazine

(1E,2E)-1-[2-(perfluorophenyl)hydrazono]non-2-en-4-ol
1402134-69-3

(1E,2E)-1-[2-(perfluorophenyl)hydrazono]non-2-en-4-ol

Conditions
ConditionsYield
With magnesium sulphate; trifluoroacetic acid at 20℃; Inert atmosphere;85%
3,5-bis(trifluoromethyl)phenylhydrazine
886-35-1

3,5-bis(trifluoromethyl)phenylhydrazine

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

(1E,2E)-1-{2-[3,5-bis(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol
1402134-67-1

(1E,2E)-1-{2-[3,5-bis(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol

Conditions
ConditionsYield
With magnesium sulphate; trifluoroacetic acid In ethanol at 20℃; Inert atmosphere;80%
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

4-(trifluoromethyl)phenylhydrazine
368-90-1

4-(trifluoromethyl)phenylhydrazine

(1E,2E)-1-{2-[4-(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol
1402134-66-0

(1E,2E)-1-{2-[4-(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol

Conditions
ConditionsYield
With magnesium sulphate; trifluoroacetic acid In acetonitrile at 20℃; for 0.25h; Inert atmosphere;80%
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

2-(trifluoromethyl)phenylhydrazine
365-34-4

2-(trifluoromethyl)phenylhydrazine

(1E,2E)-1-{2-[2-(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol
1402134-64-8

(1E,2E)-1-{2-[2-(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol

Conditions
ConditionsYield
With magnesium sulphate; trifluoroacetic acid In acetonitrile at 20℃; Inert atmosphere;76%
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

N-butylamine
109-73-9

N-butylamine

A

3-(butylamino)-1,4-nonanediol

3-(butylamino)-1,4-nonanediol

B

1,3-bis(butylamino)-4-nonanol

1,3-bis(butylamino)-4-nonanol

Conditions
ConditionsYield
Stage #1: (E)-4-Hydroxy-2-nonenal; N-butylamine With [2,2]bipyridinyl; sodium dihydrogenphosphate; copper(II) sulfate at 20℃; for 144h; pH=7.8; Condensation;
Stage #2: With sodium tetrahydroborate Reduction;
A 69%
B 6%
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

4-(trifluoromethyl)phenylhydrazine
368-90-1

4-(trifluoromethyl)phenylhydrazine

6-pentyl-1-[4-(trifluoromethyl)phenyl]-1,6-dihydropyridazine
1402134-71-7

6-pentyl-1-[4-(trifluoromethyl)phenyl]-1,6-dihydropyridazine

Conditions
ConditionsYield
With magnesium sulphate; trifluoroacetic acid In acetonitrile; tert-butyl alcohol at 70℃; for 5h;64%
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

4-(trifluoromethyl)phenylhydrazine
368-90-1

4-(trifluoromethyl)phenylhydrazine

A

6-pentyl-1-[4-(trifluoromethyl)phenyl]-1,6-dihydropyridazine
1402134-71-7

6-pentyl-1-[4-(trifluoromethyl)phenyl]-1,6-dihydropyridazine

6-pentyl-1-[4-(trifluoromethyl)phenyl]-5-{2-[4-(trifluoromethyl)-phenyl]hydrazinyl}-1,4,5,6-tetrahydropyridazine

6-pentyl-1-[4-(trifluoromethyl)phenyl]-5-{2-[4-(trifluoromethyl)-phenyl]hydrazinyl}-1,4,5,6-tetrahydropyridazine

C23H26F6N4

C23H26F6N4

Conditions
ConditionsYield
With magnesium sulphate; trifluoroacetic acid In acetonitrile at 20 - 70℃; for 6h; Inert atmosphere; optical yield given as %de; diastereoselective reaction;A 64%
B n/a
C n/a
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

3-(trifluoromethyl)phenylhydrazine
368-78-5

3-(trifluoromethyl)phenylhydrazine

(1E,2E)-1-{2-[3-(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol
1402134-65-9

(1E,2E)-1-{2-[3-(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol

Conditions
ConditionsYield
With magnesium sulphate; trifluoroacetic acid In ethanol at 20℃; Inert atmosphere;63%
[2,4-bis(trifluoromethyl)phenyl]hydrazine
1402134-63-7

[2,4-bis(trifluoromethyl)phenyl]hydrazine

(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

(1E,2E)-1-{2-[2,4-bis(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol
1402134-68-2

(1E,2E)-1-{2-[2,4-bis(trifluoromethyl)phenyl]hydrazono}non-2-en-4-ol

Conditions
ConditionsYield
With magnesium sulphate; trifluoroacetic acid at 20℃; Inert atmosphere;62%
(E)-4-Hydroxy-2-nonenal
75899-68-2

(E)-4-Hydroxy-2-nonenal

2-pentylfuran
3777-69-3

2-pentylfuran

Conditions
ConditionsYield
at 100 - 150℃;43%

75899-68-2Relevant academic research and scientific papers

Tandem IBX-Promoted Primary Alcohol Oxidation/Opening of Intermediate β,γ-Diolcarbonate Aldehydes to (E)-γ-Hydroxy-α,β-enals

Kumari, Anupama,Gholap, Sachin P.,Fernandes, Rodney A.

, p. 2278 - 2290 (2019/06/17)

A tandem IBX-promoted oxidation of primary alcohol to aldehyde and opening of intermediate β,γ-diolcarbonate aldehyde to (E)-γ-hydroxy-α,β-enal has been developed. Remarkably, the carbonate opening delivered exclusively (E)-olefin and no over-oxidation of γ-hydroxy was observed. The method developed has been extended to complete the stereoselective total synthesis of both (S)- and (R)-coriolides and d-xylo- and d-arabino-C-20 guggultetrols.

A method to produce fully characterized ubiquitin covalently modified by 4-hydroxy-nonenal, glyoxal, methylglyoxal, and malondialdehyde

Colzani, Mara,Criscuolo, Angela,Casali, Gaia,Carini, Marina,Aldini, Giancarlo

, p. 328 - 336 (2016/02/03)

Reactive carbonyl species (RCS) and the corresponding protein adducts (advanced glycoxidation or lipoxidation end products, i.e. AGEs and ALEs) are now widely studied from different points of view, since they can be considered as biomarkers, pathogenic factors, toxic mediators and drug targets. One of the main limits of the research in this field is the lack of standardized and fully characterized AGEs and ALEs to be used for biological, toxicological, and analytical studies. In this work, we set up a procedure to prepare and fully characterize a set of AGEs and ALEs by incubating ubiquitin - a model protein selected as target for carbonylation - with four different RCS: 4-hydroxy-trans-2-nonenal (HNE), methylglyoxal (MGO), glyoxal (GO), and malondialdehyde (MDA). After 24 h of incubation, the extent of protein carbonylation was estimated using a recently developed quantitative strategy based on high-resolution mass spectrometry. The resulting AGEs and ALEs were fully characterized by both intact protein and bottom-up analyses in terms of: stoichiometry of the total amount of modified protein, elucidation of the structure of the RCS-deriving adducts, and localization of the RCS-modified amino acids. Each RCS exhibited different reactivity toward ubiquitin, as detected by quantifying the extent of protein modification. The order of reactivity was MGO > GO > HNE > MDA. A variety of reaction products was identified and mapped on lysine, arginine, and histidine residues of the protein. In summary, a highly standardized and reproducible method to prepare fully characterized AGEs/ALEs is here presented.

NADP+-dependent dehydrogenase activity of carbonyl reductase on glutathionylhydroxynonanal as a new pathway for hydroxynonenal detoxification

Moschini, Roberta,Peroni, Eleonora,Rotondo, Rossella,Renzone, Giovanni,Melck, Dominique,Cappiello, Mario,Srebot, Massimo,Napolitano, Elio,Motta, Andrea,Scaloni, Andrea,Mura, Umberto,Del-Corso, Antonella

, p. 66 - 76 (2015/04/14)

An NADP+-dependent dehydrogenase activity on 3-glutathionyl-4-hydroxynonanal (GSHNE) was purified to electrophoretic homogeneity from a line of human astrocytoma cells (ADF). Proteomic analysis identified this enzymatic activity as associated with carbonyl reductase 1 (EC 1.1.1.184). The enzyme is highly efficient at catalyzing the oxidation of GSHNE (KM 33 μM, kcat 405 min-1), as it is practically inactive toward trans-4-hydroxy-2-nonenal (HNE) and other HNE-adducted thiol-containing amino acid derivatives. Combined mass spectrometry and nuclear magnetic resonance spectroscopy analysis of the reaction products revealed that carbonyl reductase oxidizes the hydroxyl group of GSHNE in its hemiacetal form, with the formation of the corresponding 3-glutathionylnonanoic-δ-lactone. The relevance of this new reaction catalyzed by carbonyl reductase 1 is discussed in terms of HNE detoxification and the recovery of reducing power.

Reactivity of (E)-4-hydroxy-2-nonenal with fluorinated phenylhydrazines: Towards the efficient derivatization of an elusive key biomarker of lipid peroxidation

Matera, Riccardo,Gabbanini, Simone,Valvassori, Alice,Triquigneaux, Mathilde,Valgimigli, Luca

experimental part, p. 3841 - 3851 (2012/09/22)

4-Hydroxynonenal (4-HNE) is a major product of the oxidation of ε-6-polyunstaturated lipids and an effector of radical-mediated oxidative damage, whose analytical determination requires chemical derivatization. In this work, its reactivity with fluorinated phenylhydrazines was explored both under preparative and analytical settings. A five-step synthesis of 4-HNE on gram-scale with an overall yield of 30% is described. Reaction of 4-HNE with ortho-, meta-, or para-CF3-phenylhydrazine, as well as with the 3,5-di-CF3, 2,4-di-CF3, or pentafluoro analogues, in MeCN with 0.5 mM TFA yields the corresponding hydrazones with rate constants k f of 2.8±0.4, 1.7±0.1, 3.0±0.2, 0.6±0.1, 0.5±0.1, and 3.5±0.5 M-1s-1, respectively at 298 K. At higher temperatures, the hydrazones undergo intramolecular cyclization to form 1,6-dihydropyridazines that, depending on the solvent and temperature, may further react with the hydrazine to yield tetrahydropyridazine adducts and their oxidation products. Other reaction products were isolated, depending on the reaction conditions, and the complex reactivity of 4-HNE with the above nucleophiles is discussed. Due to the good yield and rate of formation of the hydrazone adducts, their stability and favorable UV absorbance, 2-(trifluoromethyl)phenylhydrazine and 2,3,4,5,6-pentafluorophenylhydrazine are the most interesting candidates for the development of rapid and efficient analytical derivatizations of 4-HNE. 4-Hydroxynonenal reacts rapidly at room temperature with 2-, 3-, or 4-CF3-phenylhydrazine, or with the 3,5-di-CF3, 2,4-di-CF3, or pentafluoro analogues, to form hydrazones, which may undergo cyclization to 1,6-dihydropyridazines and other addition/oxidation products. The product distribution can be controlled by solvent and temperature to develop rapid derivatization assays. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Liquid chromatography/electrospray ionisation mass spectrometric tracking of 4-hydroxy-2(E)-nonenal biotransformations by mouse colon epithelial cells using [1,2-13C2]-4-hydroxy-2(E)-nonenal as stable isotope tracer

Jouanin,Baradat,Gieules,Tache,Pierre,Gueraud,Debrauwer

scheme or table, p. 2675 - 2681 (2012/03/10)

4-Hydroxy-2(E)-nonenal (HNE), a product of lipid peroxidation, has been extensively studied in several areas, including metabolism with radio-isotopes and quantification in various matrices with deuterium-labelled HNE as standard. The aim of this work was to evaluate the relevance of 13C-labelled HNE in biotransformation studies to discriminate metabolites from endogens by liquid chromatography/electrospray ionisation mass spectrometry (LC/ESI-MS). 13C-Labelled HNE was synthesised inimproved overall yield (20%), with the incorporation of two labels in the molecule. Immortalisedmouse colon epithelial cells were incubated with 2:3 molar amounts of HNE/13C-HNE in order to gain information on the detection of metabolites in complex media. Our results demonstrated that the stable isotope m/z values determined by mass spectrometry were relevant in distinguishing metabolites from endogens, and that metabolite structures could be deduced. Six conjugate metabolites and 4-hydroxy-2(E)-nonenoic acid were identified, together with an incompletely identified metabolite. Stable-isotope-labelled HNE has already been used for quantification purposes. However, this is the first report on the use of 13C-labelled HNE as a tracer for in vitro metabolism. 13C-Labelled HNE could also be of benefit for in vivo studies. Copyright

Design, Synthesis, ADME Properties, and Pharmacological Activities of β-Alanyl-D-histidine (D-Carnosine) Prodrugs with Improved Bioavailability

Orioli, Marica,Vistoli, Giulio,Regazzoni, Luca,Pedretti, Alessandro,Lapolla, Annunziata,Rossoni, Giuseppe,Canevotti, Renato,Gamberoni, Luca,Previtali, Massimo,Carini, Marina,Aldini, Giancarlo

body text, p. 1269 - 1282 (2012/05/20)

β-Alanyl-D-histidine (D-CAR, the enantiomer of the natural dipeptide carnosine) is a selective and potent sequestering agent of reactive carbonyl species (RCS) that is stable against carnosinase, but is poorly absorbed in the gastrointestinal tract. Herein we report a drug discovery approach aimed at increasing the oral bioavailability of D-CAR. In our study we designed, synthesized, and evaluated a series of novel lipophilic D-CAR prodrugs. The considered prodrugs can be divided into two categories: 1)derivatives with both terminal groups modified, in which the carboxyl terminus is always esterified while the amino terminus is protected by an amidic (N-acetyl derivatives) or a carbamate (ethyloxy or benzyloxy derivatives) function; 2)derivatives with only one terminus modified, which can be alkyl esters as well as amidic or carbamate derivatives. The prodrugs were designed considering their expected lipophilicity and their hydrolysis predicted by docking simulations on the most important human carboxylesterase (hCES1). The stability and metabolic profile of the prodrugs were studied by incubating them with rat and human serum and liver fractions. The octyl ester of D-CAR (compound 13) was chosen as a candidate for further pharmacological studies due to its rapid hydrolysis to the bioactive metabolite invitro. Pharmacokinetic studies in rats confirmed the invitro data and demonstrated that the oral bioavailability of D-CAR is increased 2.6-fold if given as an octyl ester relative to D-CAR. Compound 13 was then found to dose-dependently (at daily doses of 3 and 30mgkg-1 equivalent of D-CAR) decrease the development of hypertension and dyslipidemia, to restore renal functions of Zucker fa/fa obese rats, and to inhibit the carbonylation process (AGEs and pentosidine) as well as oxidative stress (urinary 8-epi-prostaglandin F2α and nitrotyrosine). A plausible mechanism underlying the protective effects of 13 is RCS sequestration, as evidenced by the significant increase in the level of adduct between CAR and 4-hydroxy-trans-2-nonenal (HNE, the main RCS generated by lipid oxidation) in the urine of treated animals. The modest oral absorption of D-carnosine (D-CAR), a bioactive compound able to detoxify reactive carbonyl species, prompted us to design, synthesize, and evaluate new lipophilic D-CAR prodrugs. Among these, D-CAR with an octyl ester has greater oral bioavailability than D-CAR, as demonstrated by pharmacokinetic studies. The new compound reduces the development of hypertension and dyslipidemia, and restores renal function in Zucker fa/fa obese rats.

Synthesis, physicochemical characterization, and biological activities of new carnosine derivatives stable in human serum as potential neuroprotective agents

Bertinaria, Massimo,Rolando, Barbara,Giorgis, Marta,Montanaro, Gabriele,Guglielmo, Stefano,Buonsanti, M. Federica,Carabelli, Valentina,Gavello, Daniela,Daniele, Pier Giuseppe,Fruttero, Roberta,Gasco, Alberto

body text, p. 611 - 621 (2011/03/20)

The synthesis and the physicochemical and biological characterization of a series of carnosine amides bearing on the amido group alkyl substituents endowed with different lipophilicity are described. All synthesized products display carnosine-like properties differentiating from the lead for their high serum stability. They are able to complex Cu2+ ions at physiological pH with the same stoichiometry as carnosine. The newly synthesized compounds display highly significant copper ion sequestering ability and are capable of protecting LDL from oxidation catalyzed by Cu2+ ions, the most active compounds being the most hydrophilic ones. All the synthesized amides show quite potent carnosine-like HNE quenching activity; in particular, 7d, the member of the series selected for this kind of study, is able to cross the blood-brain barrier (BBB) and to protect primary mouse hippocampal neurons against HNE-induced death. These products can be considered metabolically stable analogues of carnosine and are worthy of additional investigation as potential neuroprotective agents.

(2E)-4-hydroxyalk-2-enals and 2-substituted furans as products of reactions of (2E)-4,4-dimethoxybut-2-enal with Grignard compounds

Garibyan,Ovanesyan,Makaryan,Petrosyan,Chobanyan

experimental part, p. 406 - 409 (2010/09/12)

Methods have been developed for the synthesis of (2E)-1,1-dimethoxyalk-2- en-4-ols and (2E)-4-hydroxyalk-2-enals by reaction of (2E)-4,4-dimethoxybut-2- enals and Grignard compounds. Thermal isomerization of (2E)-4-hydroxyalk-2-enals gave the corresponding 2-alkylfurans.

Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives

Vila, Andrew,Tallman, Keri A.,Jacobs, Aaron T.,Liebler, Daniel C.,Porter, Ned A.,Marnett, Lawrence J.

, p. 432 - 444 (2008/12/22)

Polyunsaturated fatty acids (PUFA) are primary targets of free radical damage during oxidative stress. Diffusible electrophilic α,β- unsaturated aldehydes, such as 4-hydroxynonenal (HNE), have been shown to modify proteins that mediate cell signaling (e.g., IKK and Keap1) and alter gene expression pathways responsible for inducing antioxidant genes, heat shock proteins, and the DNA damage response. To fully understand cellular responses to HNE, it is important to determine its protein targets in an unbiased fashion. This requires a strategy for detecting and isolating HNE-modified proteins regardless of the nature of the chemical linkage between HNE and its targets. Azido or alkynyl derivatives of HNE were synthesized and demonstrated to be equivalent to HNE in their ability to induce heme oxygenase induction and induce apoptosis in colon cancer (RKO) cells. Cells exposed to the tagged HNE derivatives were lysed and exposed to reagents to effect Staudinger ligation or copper-catalyzed Huisgen 1,3 dipolar cycloaddition reaction (click chemistry) to conjugate HNE-adducted proteins with biotin for subsequent affinity purification. Both strategies yielded efficient biotinylation of tagged HNE-protein conjugates, but click chemistry was found to be superior for the recovery of biotinylated proteins from streptavidin-coated beads. Biotinylated proteins were detected in lysates from RKO cell incubations with azido-HNE at concentrations as low as 1 μM. These proteins were affinity purified with streptavidin beads, and proteomic analysis was performed by linear ion trap mass spectrometry. Proteomic analysis revealed a dose-dependent increase in labeled proteins with increased sequence coverage at higher concentrations. Several proteins involved in stress signaling (heat shock proteins 70 and 90 and the 78-kDa glucose-regulated protein) were selectively adducted by azido- and alkynyl-HNE. The use of azido and alkynyl derivatives in conjunction with click chemistry appears to be a valuable approach for the identification of the protein targets of HNE.

Synthesis of the lipid peroxidation product 4-hydroxy-2(E)-nonenal with 13C stable isotope incorporation

Jouanin,Sreevani,Rathahao,Gueraud,Paris

, p. 87 - 92 (2008/09/19)

The aim of this work was to synthesize 13C internal standards for the quantification of 4-hydroxy-2(E)-nonenal (HNE), a lipid peroxidation product, and of the etheno-adducts possibly formed by HNE damage to DNA nucleobases. We designed an eight-step synthesis starting from ethyl 2-bromoacetate and giving access to 4-[(tetrahydro-2H-pyran-2-yl)oxy]-2(E)- nonenal. This compound is a precursor of HNE. The scheme was then used to produce the 13C precursor [1,2-13C2]-4- [(tetrahydro-2H-pyran-2-yl)oxy]-2(E)-nonenal. [1,2-13C 2]HNE was obtained by acid deprotection. All the intermediary and final compounds were fully characterized by IR, HRMS, 1H and 13C NMR. It is the first synthesis of HNE which enables the incorporation of two 13C labels at determined positions. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 75899-68-2